Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 53 Neoplasms 44 Prostatic Neoplasms 43 Breast Neoplasms 38 Neoplasm Metastasis 21 Unspecified Adult Solid Tumor, Protocol Specific 19 Lung Neoplasms 18 Head and Neck Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Ovarian Neoplasms 15 Advanced Solid Tumors 11 Stomach Neoplasms 9 Sarcoma 9 Pancreatic Neoplasms 9 Solid Tumor 8 Melanoma 8 Esophageal Neoplasms 8 Carcinoma, Ovarian Epithelial 8 Urinary Bladder Neoplasms 7 Fallopian Tube Neoplasms 7 Colorectal Neoplasms 7 Small Cell Lung Carcinoma 6 Salivary Gland Neoplasms 6 Esthesioneuroblastoma, Olfactory 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Renal Cell 5 Breast Neoplasms, Male 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Endometrial Neoplasms 4

Interventions

pembrolizumab 1 Sirolimus 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1 Albumin-Bound Paclitaxel 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Cancers × Docetaxel × Clear all

NCT01019941 2010-12-16

126ASC08Q

Chong Kun Dang Pharmaceutical

Phase 1 Completed

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡